Related Experiment Videos
The DP receptor, allergic inflammation and asthma
Kenji Kabashima1, Shuh Narumiya
1Faculty of Medicine, 2nd Department of Pharmacology, Kyoto University, Yoshida-Konoe cho, Sakyo-ku, Kyoto 606-8501, Japan.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|August 5, 2003
Summary
Prostaglandin D2 (PGD2) is a key mediator in allergic diseases. Research explores its role and the DP receptor for potential therapeutic targets in conditions like asthma.
Area of Science:
- Immunology
- Allergology
- Pharmacology
Background:
- Prostaglandin D2 (PGD2) is a major arachidonic acid metabolite produced by mast cells during allergic reactions.
- PGD2's precise role in regulating allergic processes remains unclear.
- PGD2 acts via two receptors: DP and CRTH2.
Purpose of the Study:
- To investigate the regulatory role of PGD2 in allergic diseases.
- To explore the function of the DP receptor in mediating PGD2's effects.
- To assess the therapeutic potential of targeting the PGD2-DP pathway.
Main Methods:
- Review of current research on PGD2 and its receptors.
- Analysis of studies using DP-deficient mice in allergic disease models.
- Examination of DP antagonist development.
Main Results:
- DP receptor is well-characterized since 1994.
- DP antagonists are under development.
- Studies in DP-deficient mice are revealing PGD2's role in allergy.
Conclusions:
- Modulating the PGD2-DP pathway offers therapeutic potential for allergic diseases.
- Further research on DP receptor function is warranted.
- Understanding PGD2's role is crucial for developing new allergy treatments.